What is the current stock price of Biotron Limited (BITRF)?

As of the latest market data, Biotron Limited (BITRF) is trading at $0.03. The stock has seen a loss of 0.00% today.

Does Biotron Limited (BITRF) pay a dividend?

Based on current data, Biotron Limited does not have a confirmed active dividend policy.

What is the market cap of Biotron Limited?

The current market capitalization of Biotron Limited (BITRF) is approximately unavailable.

BITRF

Biotron Limited·Healthcare

0.03

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.10

Company Profile

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2013-03-22

Beta

-0.59

Websitewww.biotron.com.au↗